keyword
https://read.qxmd.com/read/38646403/a-case-of-mri-negative-leptomeningeal-disease-from-non-small-cell-lung-cancer
#1
Andrew Kokavec, Joanna Laba
Leptomeningeal disease (LMD) is a rare complication of advanced non-small cell lung cancer (NSCLC), associated with a poor prognosis. We report the case of a 55-year-old man, who presented with a metastatic NSCLC with limited brain and abdominal metastases. He was treated with both chemoimmunotherapy and stereotactic radiotherapy (SRT) to the brain. Despite treatment, the patient experienced progressive neurological symptoms not in keeping with the extent of disease seen on imaging of the brain. Due to this incongruence between symptoms and radiologic findings, he underwent a lumbar puncture, which had positive cytology for LMD...
March 2024: Curēus
https://read.qxmd.com/read/38645488/hippocampal-subfield-volumetric-changes-after-radiotherapy-for-brain-metastases
#2
JOURNAL ARTICLE
Klara Holikova, Iveta Selingerova, Petr Pospisil, Martin Bulik, Ludmila Hynkova, Ivana Kolouskova, Lucie Hnidakova, Petr Burkon, Marek Slavik, Jiri Sana, Tomas Holecek, Jiri Vanicek, Pavel Slampa, Radim Jancalek, Tomas Kazda
BACKGROUND: Changes in the hippocampus after brain metastases radiotherapy can significantly impact neurocognitive functions. Numerous studies document hippocampal atrophy correlating with the radiation dose. This study aims to elucidate volumetric changes in patients undergoing whole-brain radiotherapy (WBRT) or targeted stereotactic radiotherapy (SRT) and to explore volumetric changes in the individual subregions of the hippocampus. METHOD: Ten patients indicated to WBRT and 18 to SRT underwent brain magnetic resonance before radiotherapy and after 4 months...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38641234/salvage-stereotactic-radiosurgery-for-recurrent-who-grade-2-and-3-meningiomas-a-multicenter-study-storm
#3
JOURNAL ARTICLE
Matthew Gallitto, Geoffrey Sedor, Albert Lee, Jared Pasetsky, Connor J Kinslow, Genesis De Los Santos, Derrick Obiri-Yeboah, Varun R Kshettry, Corbin A Helis, Michael D Chan, Thomas H Beckham, Susan L McGovern, Jennifer Matsui, Joshua D Palmer, Jonathan B Bell, Eric A Mellon, David Lakomy, Jiayi Huang, Ian Boor, Chad G Rusthoven, Michael B Sisti, Tony J C Wang
PURPOSE: The role of stereotactic radiosurgery (SRS) in the management of grade 2 and 3 meningiomas is not well elucidated. Unfortunately, local recurrence rates are high, and guidelines for management of recurrent disease are lacking. To address this knowledge gap, we conducted STORM, a multicenter retrospective cohort study of patients treated with primary SRS for recurrent grade 2 and 3 meningiomas. METHODS AND MATERIALS: Data on patients with recurrent grade 2 and 3 meningioma treated with SRS at first recurrence were retrospectively collected from eight academic centers in the United States...
April 17, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38639882/short-term-predictors-of-stereotactic-radiosurgery-outcome-for-untreated-single-non-small-cell-lung-cancer-brain-metastases-a-restrospective-cohort-study
#4
JOURNAL ARTICLE
Eliseu Becco Neto, Dhiego Chaves de Almeida Bastos, Marcia Harumy Yoshikawa, Eberval Gadelha Figueiredo, Francisco de Assis de Souza Filho, Sujit Prabhu
Stereotactic radiosurgery (SRS) is an option for brain metastases (BM) not eligible for surgical resection, however, predictors of SRS outcomes are poorly known. The aim of this study is to investigate predictors of SRS outcome in patients with BM secondary to non-small cell lung cancer (NSCLC). The secondary objective is to analyze the value of volumetric criteria in identifying BM progression. This retrospective cohort study included patients >18 years of age with a single untreated BM secondary to NSCLC...
April 19, 2024: Neurosurgical Review
https://read.qxmd.com/read/38635408/cognitive-functioning-in-adults-with-autism-spectrum-disorder
#5
JOURNAL ARTICLE
Sajedeh Seyed-Alipour, Javad Alaghband-Rad, Saba Faraji, Zahra Hooshyari, Mehdi Tehranidoost, Mahtab Motamed
INTRODUCTION: Neuropsychological deficits in areas of Executive Functioning (EF), theory of mind, and central coherence have been well-documented among children and adolescents with autism spectrum disorder (ASD); however, there remains a significant gap in knowledge with regards to neuropsychological profile in adults with ASD. This study aims to investigate the intellectual functioning and neuropsychological profiles of a clinical population of adults with ASD. METHODS: This cross-sectional study included 40 available autistic individuals referred to an adult developmental disorders clinic at a hospital between 2021 and 2022...
April 18, 2024: Applied Neuropsychology. Adult
https://read.qxmd.com/read/38632075/correction-to-the-dosimetric-parameters-impact-on-local-recurrence-in-stereotactic-radiotherapy-for-brain-metastases
#6
(no author information available yet)
No abstract text is available yet for this article.
April 17, 2024: British Journal of Radiology
https://read.qxmd.com/read/38630386/improved-outcomes-for-triple-negative-breast-cancer-brain-metastases-patients-after-stereotactic-radiosurgery-and-new-systemic-approaches
#7
JOURNAL ARTICLE
Elad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, Sylvia Adams, Brandon Santhumayor, Ying Meng, Zane Schnurman, Bernadine R Donahue, Kenneth Bernstein, Cordelia Orillac, Rishitha Bollam, Maryann J Kwa, Marleen Meyers, Ruth Oratz, Yelena Novik, Joshua S Silverman, David H Harter, John G Golfinos, Douglas Kondziolka
PURPOSE: Although ongoing studies are assessing the efficacy of new systemic therapies for patients with triple negative breast cancer (TNBC), the overwhelming majority have excluded patients with brain metastases (BM). Therefore, we aim to characterize systemic therapies and outcomes in a cohort of patients with TNBC and BM managed with stereotactic radiosurgery (SRS) and delineate predictors of increased survival. METHODS: We used our prospective patient registry to evaluate data from 2012 to 2023...
April 17, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38623575/a-prospective-randomized-study-comparing-two-frameless-immobilization-systems-for-cranial-stereotactic-radiotherapy
#8
JOURNAL ARTICLE
Dylan Callens, Chahrazad Benazzouz, Lise Stessens, Wout Piot, An Nulens, Maarten Lambrecht, Patrick Berkovic, Jean-François Daisne
INTRODUCTION: The Dual Shell Encompass Fibreplast™ System (DS-Encompass) by CQ Medical™ is validated for frameless immobilization in stereotactic brain radiotherapy. An alternative mask model has been proposed with the rear shell replaced by a Moldcare® cushion (M-Encompass). To validate the use of this model in our cranial stereotactic workflow method including HyperArc™, we performed a prospective randomized study comparing inter-and intrafractional motion and patients comfort between both masks...
June 2024: Technical innovations & patient support in radiation oncology
https://read.qxmd.com/read/38623341/genomic-analysis-of-human-brain-metastases-treated-with-stereotactic-radiosurgery-reveals-unique-signature-based-on-treatment-failure
#9
JOURNAL ARTICLE
Jack M Shireman, Quinn White, Zijian Ni, Chitrasen Mohanty, Yujia Cai, Lei Zhao, Namita Agrawal, Nikita Gonugunta, Xiaohu Wang, Liam Mccarthy, Varshitha Kasulabada, Akshita Pattnaik, Atique U Ahmed, James Miller, Charles Kulwin, Aaron Cohen-Gadol, Troy Payner, Chih-Ta Lin, Jesse J Savage, Brandon Lane, Kevin Shiue, Aaron Kamer, Mitesh Shah, Gopal Iyer, Gordon Watson, Christina Kendziorski, Mahua Dey
Stereotactic radiosurgery (SRS) has been shown to be efficacious for the treatment of limited brain metastasis (BM); however, the effects of SRS on human brain metastases have yet to be studied. We performed genomic analysis on resected brain metastases from patients whose resected lesion was previously treated with SRS. Our analyses demonstrated for the first time that patients possess a distinct genomic signature based on type of treatment failure including local failure, leptomeningeal spread, and radio-necrosis...
April 19, 2024: IScience
https://read.qxmd.com/read/38619777/comparative-analysis-of-bevacizumab-and-litt-for-treating-radiation-necrosis-in-previously-radiated-cns-neoplasms-a-systematic-review-and-meta-analysis
#10
REVIEW
Neslihan Nisa Gecici, Muhammet Enes Gurses, Brandon Kaye, Natasha L Frontera Jimenez, Chandler Berke, Elif Gökalp, Victor M Lu, Michael E Ivan, Ricardo J Komotar, Ashish H Shah
PURPOSE: Radiation necrosis (RN) is a local inflammatory reaction that arises in response to radiation injury and may cause significant morbidity. This study aims to evaluate and compare the efficacy of bevacizumab and laser interstitial thermal therapy (LITT) in treating RN in patients with previously radiated central nervous system (CNS) neoplasms. METHODS: PubMed, Cochrane, Scopus, and EMBASE databases were screened. Studies of patients with radiation necrosis from primary or secondary brain tumors were included...
April 15, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38615888/dose-incorporated-deep-ensemble-learning-for-improving-brain-metastasis-srs-outcome-prediction
#11
JOURNAL ARTICLE
Jingtong Zhao, Eugene Vaios, Yuqi Wang, Zhenyu Yang, Yunfeng Cui, Zachary J Reitman, Kyle Lafata, Peter Fecci, John Kirkpatrick, Fang-Fang Yin, Scott Floyd, Chunhao Wang
PURPOSE/OBJECTIVE(S): To develop a novel deep ensemble learning model for accurate prediction of brain metastasis(BM) local control outcomes following stereotactic radiosurgery(SRS). MATERIALS/METHODS: A total of 114 BMs from 82 patients were evaluated, including 26 BMs that developed biopsy-confirmed local failure post-SRS. The SRS spatial dose distribution(Dmap ) of each BM was registered to the planning contrast-enhanced T1(T1-CE) MR. Axial slices of the Dmap , T1-CE, and PTV segmentation(PTVseg ) intersecting the BM center were extracted within a fixed field-of-view determined by the V60% in Dmap ...
April 12, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38614532/challenges-in-radiological-evaluation-of-brain-metastases-beyond-progression
#12
JOURNAL ARTICLE
A Ortiz de Mendivil, P Martín-Medina, L García-Cañamaque, B Jiménez-Munarriz, R Ciérvide, J Diamantopoulos
MRI is the cornerstone in the evaluation of brain metastases. The clinical challenges lie in discriminating metastases from mimickers such as infections or primary tumors and in evaluating the response to treatment. The latter sometimes leads to growth, which must be framed as pseudo-progression or radionecrosis, both inflammatory phenomena attributable to treatment, or be considered as recurrence. To meet these needs, imaging techniques are the subject of constant research. However, an exponential growth after radiotherapy must be interpreted with caution, even in the presence of results suspicious of tumor progression by advanced techniques, because it may be due to inflammatory changes...
2024: Radiología
https://read.qxmd.com/read/38611601/diagnostic-and-therapeutic-particularities-of-symptomatic-melanoma-brain-metastases-from-case-report-to-literature-review
#13
Adelaida Avino, Daniela-Elena Ion, Daniela-Elena Gheoca-Mutu, Abdalah Abu-Baker, Andrada-Elena Țigăran, Teodora Peligrad, Cristian-Sorin Hariga, Andra-Elena Balcangiu-Stroescu, Cristian-Radu Jecan, Adrian Tudor, Laura Răducu
The recent introduction of immunotherapy and targeted therapy has substantially enriched the therapeutic landscape of metastatic melanoma. However, cerebral metastases remain unrelenting entities with atypical metabolic and genetic profiles compared to extracranial metastases, requiring combined approaches with local ablative treatment to alleviate symptoms, prevent recurrence and restore patients' biological and psychological resources for fighting malignancy. This paper aims to provide the latest scientific evidence about the rationale and timing of treatment, emphasizing the complementary roles of surgery, radiotherapy, and systemic therapy in eradicating brain metastases, with a special focus on the distinct response of intracranial and extracranial disease, which are regarded as separate molecular entities...
March 25, 2024: Diagnostics
https://read.qxmd.com/read/38610944/a-biopsy-controlled-prospective-study-of-contrast-enhancing-diffuse-glioma-infiltration-based-on-fet-pet-and-flair
#14
JOURNAL ARTICLE
Maciej Harat, Izabela Miechowicz, Józefina Rakowska, Izabela Zarębska, Bogdan Małkowski
Accurately defining glioma infiltration is crucial for optimizing radiotherapy and surgery, but glioma infiltration is heterogeneous and MRI imperfectly defines the tumor extent. Currently, it is impossible to determine the tumor infiltration gradient within a FLAIR signal. O-(2-[18F]fluoroethyl)-L-tyrosine (FET)-PET often reveals high-grade glioma infiltration beyond contrast-enhancing areas on MRI. Here, we studied FET uptake dynamics in tumor and normal brain structures by dual-timepoint (10 min and 40-60 min post-injection) acquisition to optimize analysis protocols for defining glioma infiltration...
March 24, 2024: Cancers
https://read.qxmd.com/read/38595077/early-experience-with-biologically-effective-dose-comparable-short-course-whole-brain-radiation-therapy-for-metastatic-intracranial-disease
#15
JOURNAL ARTICLE
Shearwood McClelland
BACKGROUND: For inpatients with metastatic intracranial disease burden exceeding established guidelines for stereotactic radiosurgery (SRS), the standard of care involves whole brain radiation therapy (WBRT), typically administered as a 2-week course of treatment with biologically effective dose (BED) of 60 Gy. However, shorter course WBRT provides theoretical advantages in quality of life and decreasing systemic therapy delay. This retrospective study evaluates our early experience with BED-comparable short-course WBRT (23 Gy in 5 fractions; BED=58...
April 9, 2024: American Journal of Clinical Oncology
https://read.qxmd.com/read/38589800/rational-and-design-of-prophylactic-cranial-irradiation-pci-and-brain-mri-surveillance-versus-brain-mri-surveillance-alone-in-patients-with-limited-stage-small-cell-lung-cancer-achieving-complete-remission-cr-of-tumor-after-chemoradiotherapy-a-multicenter-prospective
#16
RANDOMIZED CONTROLLED TRIAL
Mengyuan Chen, Runhua Li, Yue Kong, Lei Shi, Jing Wang, Yuezhen Wang, Yujin Xu, Yongling Ji, Xiao Hu
BACKGROUND: Prophylactic cranial irradiation (PCI) is part of standard care in limited-stage small cell lung cancer (SCLC) at present. As evidence from retrospective studies increases, the benefits of PCI for limited-stage SCLC are being challenged. METHODS: A multicenter, prospective, randomized controlled study was designed. The key inclusion criteria were: histologically or cytologically confirmed small cell carcinoma, age ≥ 18 years, KPS ≥ 80, limited-stage is defined as tumor confined to one side of the chest including ipsilateral hilar, bilateral mediastinum and supraclavicular lymph nodes, patients have received definitive thoracic radiotherapy (regardless of the dose-fractionation of radiotherapy used) and chemotherapy, evaluated as complete remission (CR) of tumor 4-6 weeks after the completion of chemo-radiotherapy...
April 8, 2024: BMC Cancer
https://read.qxmd.com/read/38588920/re-irradiation-for-recurrent-intracranial-meningiomas-analysis-of-clinical-outcomes-and-prognostic-factors
#17
JOURNAL ARTICLE
Isacco Desideri, Ilaria Morelli, Marco Banini, Daniela Greto, Luca Visani, Filippo Nozzoli, Saverio Caini, Alessandro Della Puppa, Lorenzo Livi, Zeno Perini, Emanuele Zivelonghi, Giorgia Bulgarelli, Valentina Pinzi, Pierina Navarria, Elena Clerici, Marta Scorsetti, Anna Maria Ascolese, Mattia Falchetto Osti, Paola Anselmo, Dante Amelio, Giuseppe Minniti, Daniele Scartoni
PURPOSE: Re-irradiation (re-RT) for recurrent intracranial meningiomas is hindered by the limited radiation tolerance of surrounding tissue and the risk of side effects. This study aimed at assessing outcomes, toxicities and prognostic factors in a cohort of patients with recurrent meningiomas re-treated with different RT modalities. MATERIALS AND METHODS: A multi-institutional database from 8 Italian centers including intracranial recurrent meningioma (RM) patients who underwent re-RT with different modalities (SRS, SRT, PT, EBRT) was collected...
April 7, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38584868/assessing-the-impact-of-distortion-correction-on-gamma-knife-radiosurgery-for-multiple-metastasis-volumetric-and-dosimetric-analysis
#18
JOURNAL ARTICLE
Yavuz Samanci, M Orbay Askeroglu, Ali Haluk Düzkalir, Selcuk Peker
INTRODUCTION: Magnetic resonance imaging (MRI) is a robust neuroimaging technique and is the preferred method for stereotactic radiosurgery (SRS) planning. However, MRI data always contain distortions caused by hardware and patient factors. RESEARCH QUESTION: Can these distortions potentially compromise the effectiveness and safety of SRS treatments? MATERIAL AND METHODS: Twenty-six MR datasets with multiple metastatic brain tumors (METs) used for Gamma Knife radiosurgery (GKRS) were retrospectively evaluated...
2024: Brain Spine
https://read.qxmd.com/read/38572153/repetitive-transcranial-magnetic-stimulation-for-alzheimer-s-disease-an-overview-of-systematic-reviews-and-meta-analysis
#19
Hua Xue, Ya-Xin Li, Ya-Song Xiao, Wen-Hui Fan, Hong-Xian He
OBJECTIVE: Alzheimer's disease (AD) is a prevalent neurodegenerative condition that significantly impacts both individuals and society. This study aims to evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a treatment for AD by summarizing the evidence from systematic reviews (SRs) and meta-analyses (MAs). METHODS: SRs/MAs of rTMS for AD were collected by searching Embase, Web of Science, Cochrane Library, PubMed, CNKI, VIP, Sino-Med, and Wanfang databases...
2024: Frontiers in Aging Neuroscience
https://read.qxmd.com/read/38569013/assessing-the-sensitivity-and-suitability-of-a-range-of-detectors-for-simt-psqa
#20
JOURNAL ARTICLE
Leon Dunn, Alessia Tamborriello, Brindha Subramanian, Xiaolei Xu, Tyrone Te Ruruku
PURPOSE: Single-isocenter multi-target intracranial stereotactic radiotherapy (SIMT) is an effective treatment for brain metastases with complex treatment plans and delivery optimization necessitating rigorous quality assurance. This work aims to assess five methods for quality assurance of SIMT treatment plans in terms of their suitability and sensitivity to delivery errors. METHODS: Sun Nuclear ArcCHECK and SRS MapCHECK, GafChromic EBT Radiochromic Film, machine log files, and Varian Portal Dosimetry were all used to measure 15 variations of a single SIMT plan...
April 3, 2024: Journal of Applied Clinical Medical Physics
keyword
keyword
170316
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.